The dismissed cancer tech assessment

12 August 2019 0

Despite the prominent global debate on the ethics of technology and the increasing need for technology assessment before approval, anticipatory approaches, especially in oncology, are still in their infancy  In the age of artificial intelligence [more]

In the age of artificial intelligence (AI), big data and machine learning, technology assessment is becoming a necessity to ensure the approval of new technologies and devices by regulatory agencies. The explosion of applications ... [ more ]

Radio-immunotherapy, a work in progress

5 August 2019 0

The potential for combining radiotherapy with immunotherapy is enormous, yet experts say that radio-immunotherapy still has a long way to go before entering into routine clinical practice One of the hot topics discussed at ESTRO38, [more]

The potential for combining radiotherapy with immunotherapy is enormous, yet experts say that radio-immunotherapy still has a long way to go before entering into routine clinical practice. One of the hot topics discussed at ESTRO3... [ more ]

The big challenge of treating adolescents and young adults with cancer

No longer children and not yet adults, adolescents and young adults with cancer represent a specific patient population posing outstanding challenges to oncologists all over the world. Challenging but rewarding. This is how physicians described [more]

No longer children and not yet adults, adolescents and young adults with cancer represent a specific patient population posing outstanding challenges to oncologists all over the world.... [ more ]

Dr. Fraud’s jungle, where science is the prey

22 July 2019 0

With the advent of Open Access – a new publishing model that asks researchers to pay to make their research publicly accessible – unscrupulous predators were granted easy access to a house full of naïve and ingenuous scientists and doctors, and today thrive at their expense, and at the expense of science, including cancer research. [more]

... [ more ]